报道

订阅

MedSci主页 / 所有栏目 / 报道

倒计时：BMJ Open**课程资料，教你21天从0到写出protocol，还不快来？

2017-07-02 MedSci MedSci原创

方案设计课表
关注

MedSci邀请了5位经验丰富的讲师并携手BMJ Open，共同设计的课表终于出炉啦！ 我们精心打造10堂课，建群并手把手教你如何做设计！



今天就要直播啦！！

MedSci邀请了5位经验丰富的讲师并携手BMJ Open，共同设计的课表终于出炉啦！
我们精心打造10堂课，建群并手把手教你如何做设计！



*19：30直播形式

*直播结束可获得独家BMJ Open课程中文资料


友情提示：
本大赛报名费50（汇款务必备注与报名表一致的姓名），邀请4位好友，可获赠一人免费资格！
课程为19：30直播形式，参赛者所有申请信息均适用于MedSci保密条例，群内学习的资料一律严禁外传。
若缴费后未加入qq群，可联系邮箱：yingzheng.gu@medsci.cn


版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1848339, encodeId=69721848339d9, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Feb 14 23:00:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1726539, encodeId=a7cc1e265398c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Aug 13 19:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634918, encodeId=03f6163491804, content=<a href='/topic/show?id=c23314e6733' target=_blank style='color:#2F92EE;'>#protocol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14767, encryptionId=c23314e6733, topicName=protocol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63bb22340010, createdName=12498561m39(暂无昵称), createdTime=Mon Nov 13 15:00:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218574, encodeId=67f02185e4be, content= 已付费，紧急联系邮箱无回音, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/06/12855da6afb4c24a34ee62586ec5baae.JPG, createdBy=0edf2084835, createdName=181****1972, createdTime=Tue Jul 04 19:33:08 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601889, encodeId=9e77160188926, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Mon Jul 03 15:00:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217234, encodeId=ee6c21e23471, content=学习了，涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Jun 30 23:34:46 CST 2017, time=2017-06-30, status=1, ipAttribution=)]
    2018-02-14 gaoxiaoe

    #BMJ#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1848339, encodeId=69721848339d9, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Feb 14 23:00:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1726539, encodeId=a7cc1e265398c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Aug 13 19:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634918, encodeId=03f6163491804, content=<a href='/topic/show?id=c23314e6733' target=_blank style='color:#2F92EE;'>#protocol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14767, encryptionId=c23314e6733, topicName=protocol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63bb22340010, createdName=12498561m39(暂无昵称), createdTime=Mon Nov 13 15:00:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218574, encodeId=67f02185e4be, content= 已付费，紧急联系邮箱无回音, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/06/12855da6afb4c24a34ee62586ec5baae.JPG, createdBy=0edf2084835, createdName=181****1972, createdTime=Tue Jul 04 19:33:08 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601889, encodeId=9e77160188926, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Mon Jul 03 15:00:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217234, encodeId=ee6c21e23471, content=学习了，涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Jun 30 23:34:46 CST 2017, time=2017-06-30, status=1, ipAttribution=)]
    2017-08-13 feather89

    #PE#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1848339, encodeId=69721848339d9, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Feb 14 23:00:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1726539, encodeId=a7cc1e265398c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Aug 13 19:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634918, encodeId=03f6163491804, content=<a href='/topic/show?id=c23314e6733' target=_blank style='color:#2F92EE;'>#protocol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14767, encryptionId=c23314e6733, topicName=protocol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63bb22340010, createdName=12498561m39(暂无昵称), createdTime=Mon Nov 13 15:00:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218574, encodeId=67f02185e4be, content= 已付费，紧急联系邮箱无回音, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/06/12855da6afb4c24a34ee62586ec5baae.JPG, createdBy=0edf2084835, createdName=181****1972, createdTime=Tue Jul 04 19:33:08 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601889, encodeId=9e77160188926, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Mon Jul 03 15:00:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217234, encodeId=ee6c21e23471, content=学习了，涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Jun 30 23:34:46 CST 2017, time=2017-06-30, status=1, ipAttribution=)]
    2017-11-13 12498561m39(暂无昵称)

    #protocol#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1848339, encodeId=69721848339d9, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Feb 14 23:00:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1726539, encodeId=a7cc1e265398c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Aug 13 19:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634918, encodeId=03f6163491804, content=<a href='/topic/show?id=c23314e6733' target=_blank style='color:#2F92EE;'>#protocol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14767, encryptionId=c23314e6733, topicName=protocol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63bb22340010, createdName=12498561m39(暂无昵称), createdTime=Mon Nov 13 15:00:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218574, encodeId=67f02185e4be, content= 已付费，紧急联系邮箱无回音, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/06/12855da6afb4c24a34ee62586ec5baae.JPG, createdBy=0edf2084835, createdName=181****1972, createdTime=Tue Jul 04 19:33:08 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601889, encodeId=9e77160188926, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Mon Jul 03 15:00:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217234, encodeId=ee6c21e23471, content=学习了，涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Jun 30 23:34:46 CST 2017, time=2017-06-30, status=1, ipAttribution=)]
    2017-07-04 181****1972

    已付费，紧急联系邮箱无回音

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1848339, encodeId=69721848339d9, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Feb 14 23:00:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1726539, encodeId=a7cc1e265398c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Aug 13 19:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634918, encodeId=03f6163491804, content=<a href='/topic/show?id=c23314e6733' target=_blank style='color:#2F92EE;'>#protocol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14767, encryptionId=c23314e6733, topicName=protocol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63bb22340010, createdName=12498561m39(暂无昵称), createdTime=Mon Nov 13 15:00:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218574, encodeId=67f02185e4be, content= 已付费，紧急联系邮箱无回音, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/06/12855da6afb4c24a34ee62586ec5baae.JPG, createdBy=0edf2084835, createdName=181****1972, createdTime=Tue Jul 04 19:33:08 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601889, encodeId=9e77160188926, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Mon Jul 03 15:00:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217234, encodeId=ee6c21e23471, content=学习了，涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Jun 30 23:34:46 CST 2017, time=2017-06-30, status=1, ipAttribution=)]
    2017-07-03 sunylz

    #PRO#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1848339, encodeId=69721848339d9, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Feb 14 23:00:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1726539, encodeId=a7cc1e265398c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Aug 13 19:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634918, encodeId=03f6163491804, content=<a href='/topic/show?id=c23314e6733' target=_blank style='color:#2F92EE;'>#protocol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14767, encryptionId=c23314e6733, topicName=protocol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63bb22340010, createdName=12498561m39(暂无昵称), createdTime=Mon Nov 13 15:00:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218574, encodeId=67f02185e4be, content= 已付费，紧急联系邮箱无回音, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/06/12855da6afb4c24a34ee62586ec5baae.JPG, createdBy=0edf2084835, createdName=181****1972, createdTime=Tue Jul 04 19:33:08 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601889, encodeId=9e77160188926, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Mon Jul 03 15:00:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217234, encodeId=ee6c21e23471, content=学习了，涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Jun 30 23:34:46 CST 2017, time=2017-06-30, status=1, ipAttribution=)]
    2017-06-30 1ddf0692m34(暂无匿称)

    学习了，涨知识

    0

相关资讯

我的设计我做主：MedSci临床研究方案设计活动

任务目标：完成一份辅助生殖相关的临床研究设计 规则：我们会在微信群中每周陆续公布临床研究立题及设计要素的相关信息，请大家进行互动和投票，在一周后对投票结果进行汇总并公布结果；同时会发布下一个任务（参考“任务清单”），拟通过4-6周的讨论，最终完成一个临床研究设计方案。 期间大家也可以针对任务组织线上和线下的讨论，并向MedSci的人员提出问题，我们会定期集中答疑，也会提供一些与

我的设计我做主：MedSci临床研究方案设计活动-立题公布（1）

【我的设计我做主】MedSci临床研究方案设计活动 任务目标：完成一份辅助生殖相关的临床研究设计 在发布的立题选项中，看下方 任务一（2015.5.11发布）：临床研究立题（方向） 请各位从以下研究立题中选择一个，开展后续的研究设计任务： A. 卵巢低反应对于IVF妊娠结局的影响 B. OHSS发生的相关风险因素 C. XX激素水平（或者其他b

我的设计我做主：MedSci临床研究方案设计活动-立题公布（2）

前提示：【我的设计我做主】MedSci临床研究方案设计活动-立题公布（1）对于肥胖或体重超标者实施体重控制或干预（减轻体重）对于IVF妊娠结局的影响对于肥胖或体重超标者实施体重控制或干预（减轻体重）对于IVF妊娠结局的影响 相关的研究成果不少（fig 1 Pubmed上粗略的检索结果），正在进行或已经结束的注册研究也有一些（fig 2 www.clinicaltrials.gov上注册的研究，

临床方案设计训练营21天从0到投稿，敢挑战吗？

临床研究设计是临床研究的灵魂，也是核心步骤之一。优秀临床研究成果是最终的花与果，但是必需要有坚实强壮的根基，才能造就源源不断的成果。在转化医学与循证医学日渐普及的当下，您开始自己设计临床研究了吗？您选择的这个课题操作上时候哦具有可行性，易于实施，且具有较高的临床指导价值？您的课题具有创新性的同时，时候遵循了座机临床研究规范？如果您对您的临床研究足够自信，或者还希望知道本研究设计存在哪些待改进的地方

我的设计我做主：MedSci临床研究方案设计活动（第二轮）

任务目标：完成一份辅助生殖相关的临床研究设计规则：我们会在微信群中每周陆续公布临床研究立题及设计要素的相关信息，请大家进行互动和投票，在一周后对投票结果进行汇总并公布结果；同时会发布下一个任务（参考“任务清单”），拟通过4-6周的讨论，最终完成一个临床研究设计方案。期间大家也可以针对任务组织线上和线下的讨论，并向MedSci的人员提出问题，我们会定期集中答疑，也会提供一些与本研究课题相关的文献资料

梅斯医学携手BMJ Open打造：21天从0到写出protocol，敢挑战吗？

MedSci邀请了5位经验丰富的讲师并携手BMJ open，共同设计了课表，精心打造10堂课，建群并手把手教你如何做设计。